Report a possible side effect

At GSK we take the safety of our patients very seriously. We know that side effects can happen, but it is not always possible to predict who will experience them. We continuously monitor the safety of our products and by hearing about your experiences we can offer the best possible advice to people using our products.

How to report a possible side effect?

To help us process your information quickly and effectively, please report as much relevant information as possible.  At a minimum you will need to provide the following:

  1. The initials of the person who experienced the possible side effect and/or other identifiers, such as gender, date of birth
  2. The contact information of the person reporting the issue
  3. A description of the possible side effect, such as the signs and symptoms experienced, date the possible side effect started and the result of the possible side effect
  4. The name of the GSK product

Our Privacy Notice outlines how we handle the processing of personal information when dealing with your enquiry, complaint or adverse event report.

For contact details and to report a possible side effect, please select your home market from the list below.

Algeria

Telephone number:

+21324843220

Email address:

pharmacovigilance.dz@gsk.com

Bahrain

Email address:

gulf.safety@gsk.com

Benin

Email address:

mu.zinchub@gsk.com

 

Burundi

Email address:

mu.zinchub@gsk.com

Cambodia & Laos

Telephone number:

Cambodia:+85523212838

Laos:+85512811337

Email address:

pharmacovigilance.cambodia@gsk.com

Cameroon

Email address:

mu.zinchub@gsk.com

Central African Republic 

Email address:

mu.zinchub@gsk.com

Chad

Email address:

mu.zinchub@gsk.com

Congo Brazzaville 

Email address:

mu.zinchub@gsk.com

Cote d’Ivoire

Email address:

mu.zinchub@gsk.com

Democratic Republic of the Congo

Email address:

mu.zinchub@gsk.com

Djibouti

Email address:

mu.zinchub@gsk.com

Egypt

Telephone number:

+20 (2) 2618-515 

Email address:

ae.egypt@gsk.com

Ethiopia

Email address:

mu.zinchub@gsk.com

Gabon

Email address:

mu.zinchub@gsk.com

Ghana

Email address:

mu.zinchub@gsk.com

Guinea 

Email address:

mu.zinchub@gsk.com

Gulf & Near East

Telephone number:

Gulf Tel: +97144037100
Near East: +9611449646

Email address:

Gulf: gulf.safety@gsk.com
Near East: NE.Safety@gsk.com

Iran

Telephone number: 

(+98-21)26309488
(+98-21)26309588
(+98-21)26309788
(+98-21)26309656

– EXT:1001

Email address:

NE.Safety@gsk.com

Iraq

Telephone number:

+9611449646

Email address:

NE.Safety@gsk.com

Israel

Telephone number:

+97239297100

Email address:

il.safety@gsk.com

Jordan

Telephone number:

+96265104256

Email address:

NE.Safety@gsk.com

Kazakhstan

GSK Pharmacovigilance Hub in the Eurasian Economic Union

Telephone number:

+77272582892

Email address:

kz.safety@gsk.com 

Kenya

Telephone number:

+254206933200

Email address:

ke.safety@gsk.com

 

Kuwait

Email address:

gulf.safety@gsk.com

Lebanon

Telephone number:

+9611449646

Email address:

NE.Safety@gsk.com

Liberia

Email address:

mu.zinchub@gsk.com

 

Libya

Telephone number:

+9611449646

Email address:

NE.Safety@gsk.com

Mali

Email address:

mu.zinchub@gsk.com

Morroco

Email address:

pharmacovigilance.na@gsk.com

Niger

Email address:

mu.zinchub@gsk.com

Nigeria

Telephone number (out of office hours):

+08002255475

Email address:

aereporting.ng@gsk.com

 

Oman

Email address:

gulf.safety@gsk.com

Qatar

Email address:

gulf.safety@gsk.com

Rwanda

Email address:

mu.zinchub@gsk.com

Saudi Arabia

Telephone number:

+966569049882

Email address:

saudi.safety@gsk.com

Senegal

Email address:

mu.zinchub@gsk.com

Sierra Leone

Email address:

mu.zinchub@gsk.com

South Africa

Telephone number:

+27117456000

Email address:

aereporting.za@gsk.com

Southern Africa

Email address:

mu.zinchub@gsk.com

Sudan North

Telephone number:

+9611449646

Email Address

NE.Safety@gsk.com

Syria

Telephone number:

+9611449646

Email address:

NE.Safety@gsk.com

Tanzania

Email address:

mu.zinchub@gsk.com

 

Togo

Email address:

mu.zinchub@gsk.com

Tunisia

Email address:

pharmacovigilance.na@gsk.com

Uganda

Email address:

mu.zinchub@gsk.com

 

United Arab Emirates

Email address:

gulf.safety@gsk.com

Western & Central Africa

Email address:

mu.zinchub@gsk.com

Yemen

Telephone number:

+9611449646

Email address:

NE.Safety@gsk.com

Zambia

Email address:

mu.zinchub@gsk.com

Zimbabwe

Email address:

mu.zinchub@gsk.com

Argentina

Telephone number:

+541147258900

Email address:

Bua-Farmacovigilancia-Rx@gsk.com

Bolivia and Paraguay

Telephone number:

+541147258900

Email address:

Bua-Farmacovigilancia-Rx@gsk.com

Brazil

Telephone number:

Monday-Friday 8am to 5pm:

+08007012233

+08000211529

Email address:

farmacovigilancia@gsk.com  

Canada

Telephone number:

+18003877374

Email address:

drugsurv.a.ca@gsk.com

Chile

Telephone number:

+56223829000 

Email address:

farmacovigilancia.chile@gsk.com

 

 

Colombia

Telephone number:

+18000118686

Email address:

programa.dirmedica@gsk.com

Costa Rica

Telephone number:

+(506)40554242

Email address:

fv.aecaricam@gsk.com

Dominican-Republic

Telephone number:

+18299566335

Email address:

fv.aecaricam@gsk.com

 

Ecuador

Telephone number:

+59322994700 Ext. 5

Email address:

farmacovigilancia.ecuador@gsk.com

El-Salvador

Telephone number:

+(503)21367801

Email address:

fv.aecaricam@gsk.com

Guatemala

Telephone number:

+(502)23761930

Email address:

fv.aecaricam@gsk.com

Honduras

Telephone number:

+(504)25401638

Email address:

fv.aecaricam@gsk.com

Jamaica

Telephone number:

+18766302074

Email address:

fv.aecaricam@gsk.com

Mexico

Telephone number (toll free):

5554835200

Email address:

farmacovigilancia.mx@gsk.com

Nicaragua

Telephone number:

+(505)27222215

Email address:

fv.aecaricam@gsk.com

Panama

Telephone number:

+(507)8336768

Email address:

fv.aecaricam@gsk.com 

Peru

Telephone number:

+5112119700

Email address:

farmacovigilancia.peru@gsk.com

Trinidad and Tobago

Telephone number:

+18682245759

Email address:

fv.aecaricam@gsk.com

Uruguay

Telephone number:

+59824198333 

Email address:

uy.farmacovigilancia@gsk.com

USA

To report a possible side effect:

Online: Patient safety reporting form

Tel: +1 888 825 5249

Email: WW.GSKAEReportingUS@gsk.com

Venezuela

Telephone number:

+58 261 3350960

Email address:

ven.farmacovigilancia@gsk.com

Afghanistan

Telephone number:

+9611449646

Email address:

NE.Safety@gsk.com

Armenia

GSK Pharmacovigilance Hub in the Eurasian Economic Union

Telephone number:

+74957778900

Email address:

ru.safety@gsk.com

Australia

To report a possible side effect:

Online: Adverse event reporting form

Tel: 1800 033 109 or +61 3 9413 7200

 

 

 

Azerbaijan

Email address:

oax70065@gsk.com

Bangladesh

Email address:

oax70065@gsk.com

Cambodia

Email address:

ADC.safety@gsk.com

China (Mainland)

Telephone number:

+868008203383

+864001833383

Email address:

oax32250@gsk.com

Hong Kong and Macau

Telephone number:

+85231898989

Email address:

HKAdverseEvent@gsk.com

India

Toll free number:

+1800222203

Telephone number:

+912224959595

Mobile number:

+018002769263

Email:

india.pharmacovigilance@gsk.com

Indonesia

Telephone number:

+622125532350

Email address:

yqq68540@gsk.com

 

Japan

Email address:

JP.ADR-JDMA@gsk.com

Korea

Telephone number

+82809014100

E-mail address

kr-medical.drug-safety@gsk.com

Kyrgyzstan

GSK Pharmacovigilance Hub in the Eurasian Economic Union

Telephone number:

+74957778900

Email address:

ru.safety@gsk.com

Laos

Email address:

ADC.safety@gsk.com

Malaysia & Brunei

Email address:

drugsafetyinfo.my@gsk.com

Mongolia

Email address:

oax70065@gsk.com

Myanmar

Email address:

ADC.safety@gsk.com

New Zealand

To report a possible side effect:

Online: Adverse event reporting form

Tel: 0800 808 500 or +64 9 367 2900

 

 

Pakistan 

Telephone number:

+9221111475725

Email address:

pk_pharmasafety@gsk.com

Philippines

Telephone number:

GSK Philippines : +632 8892 0761

email address:

ph.safety@gsk.com

 

Singapore

Email address:

sg.drugsafety@gsk.com

Sri-Lanka

Email address:

lk.pharmacovigilance@gsk.com

Taiwan

Telephone number:

+886223126836

Email address:

oax40892@gsk.com

Tajikistan

Email address:

oax70065@gsk.com

Thailand

Email address:

safety_th@gsk.com

Turkmenistan

Email address:

oax70065@gsk.com

Email address:

oax70065@gsk.com

Vietnam

Telephone number:

Tel: +84 28 3824 8744
Mob: +84 96390 5235

Email address:

antoanthuoc.vn@gsk.com

Albania

Telephone number:

+35542232855 +355692044295

Email address:

s.riza@megapharm.al

e.arapi@megapharm.al

Website address:

www.megapharm.al

 

Kosovo

Telephone number:

+38338600776

Austria

Telephone number:

+431970750

Email address:

arzneimittelsicherheit@gsk.com

Belarus

GSK Pharmacovigilance Hub in the Eurasian Economic Union

Telephone number:

+74957778900

Email address:

ru.safety@gsk.com

 

Belgium

Telephone number:

+3210855200

Email address:

be.medinfo@gsk.com

Bosnia & Herzegovina

Telephone number:

+387(0)33774300

Email address:

pv@elpharma.ba

Bulgaria

Telephone number:

+35980018205

Email address:

safety-bg@gsk.com

Croatia

Telephone number:

+385800787089

Email address:

cro.nuspojave@gsk.com

Cyprus

Telephone number:

+35780070017

Email address:

cy.safety@gsk.com

Czech-Republic

Email address:

cz.safety@gsk.com

Denmark

Telephone number:

+4536359100

Email address:

dk-safety@gsk.com

Estonia

Telephone number:

+3728002640

Email address:

estoniansafety@gsk.com   

Finland

Telephone number:

+35810303030

Report an adverse event online:

France

Telephone number:

+33139178444

Email address:

diam@gsk.com

Georgia

Email address:

oax70065@gsk.com

Germany

Email address:

Drug-Safety.Germany@gsk.com

 

Greece

Telephone number:

+302106882100

Email address:

gr.pharmacovigilance@gsk.com

Hungary

Telephone number:

+3680088309 

Email address:

Hungary.PH_Safety@gsk.com  

Iceland

Telephone number:

+4536359100

Email address:

dk-safety@gsk.com

Ireland

To report a possible side effect:

Online: Patient safety reporting form

Tel: 1800 244 255

Email: Ireland.Drugsurveillance@gsk.com

 

Italy

Telephone number:

+390457748005

Email address:

drugsurveillance-italy@gsk.com

 

Latvia

Telephone number:

+37180205045

Email address:

quz52333@gsk.com

Lithuania

Telephone number:

+37080000334

Email address:

safety.lt@gsk.com

Luxembourg

Telephone number:

+3210855200

Email address:

be.medinfo@gsk.com

 

Malta

Telephone number:

+35680065004

Email address:

mt.safety@gsk.com

 

 

Moldova

Email address:

oax70065@gsk.com

Montenegro

Telephone number:

+382(0)77272735

Email address:

pv@elpharma.me

Netherlands

Telephone number:

+31332081100

Email address:

nl.bijwerking@gsk.com

North Macedonia

Telephone number:

+389(0)22786074

+389(0)22700573

Email address:

pharmacovigilance@elpharma.com.mk

Norway

Telephone number:

+4722702000

Email address:

no.safety@gsk.com

Poland

Telephone number:

+48225769000

Email address:

uyz84328@gsk.com

Portugal

Telephone number:

+351214129500

Email address:

LIS.Nucleo-Farmacovigilancia@gsk.com

Romania

Telephone number:

+40 800672524

Email address:

farmacovigilenta.romania@gsk.com

 

Russia

GSK Pharmacovigilance Hub in the Eurasian Economic Union

Telephone number:

+74957778900

Email address:

ru.safety@gsk.com

Serbia

Email address:

drugsafety@elpharma.com

Slovakia

Telephone number:

+421800500589

Email address:

sk-safety@gsk.com

Telephone number:

+38680688869

Email address:

LJU.farmakovigilanca@gsk.com

 

 

Spain

Telephone number:

(+34)900202700

Email address:

unidad.farmacovigilancia@gsk.com

Sweden

Telephone number:

+4686389300

Website address:

Report an adverse event online

Switzerland

Telephone number:

+41318622111

Email address:

pv.swiss@gsk.com

For ViiV Healthcare products please consult:

pv.swiss@gsk.com or +41315607670

Turkey

Telephone number:

+902124445475

Email address:

IST_TR_safety@gsk.com

Ukraine 

Telephone number:

+380445855185 

Email address:

oax70065@gsk.com

United Kingdom

To report a possible side effect:

Online: Patient safety reporting form

Tel: 0800 221 441

Email: uksafety@gsk.com